276 related articles for article (PubMed ID: 28069926)
21. Apoptosis of Oligodendrocytes during Early Development Delays Myelination and Impairs Subsequent Responses to Demyelination.
Caprariello AV; Batt CE; Zippe I; Romito-DiGiacomo RR; Karl M; Miller RH
J Neurosci; 2015 Oct; 35(41):14031-41. PubMed ID: 26468203
[TBL] [Abstract][Full Text] [Related]
22. Transgenic overexpression of Sox17 promotes oligodendrocyte development and attenuates demyelination.
Ming X; Chew LJ; Gallo V
J Neurosci; 2013 Jul; 33(30):12528-42. PubMed ID: 23884956
[TBL] [Abstract][Full Text] [Related]
23. Sustained ErbB Activation Causes Demyelination and Hypomyelination by Driving Necroptosis of Mature Oligodendrocytes and Apoptosis of Oligodendrocyte Precursor Cells.
Hu X; Xiao G; He L; Niu X; Li H; Lou T; Hu Q; Yang Y; Xu Q; Wei Z; Qiu M; Tanaka KF; Shen Y; Tao Y
J Neurosci; 2021 Dec; 41(48):9872-9890. PubMed ID: 34725188
[TBL] [Abstract][Full Text] [Related]
24. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
[TBL] [Abstract][Full Text] [Related]
25. PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination.
Murtie JC; Zhou YX; Le TQ; Vana AC; Armstrong RC
Neurobiol Dis; 2005; 19(1-2):171-82. PubMed ID: 15837572
[TBL] [Abstract][Full Text] [Related]
26. Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.
Rone MB; Cui QL; Fang J; Wang LC; Zhang J; Khan D; Bedard M; Almazan G; Ludwin SK; Jones R; Kennedy TE; Antel JP
J Neurosci; 2016 Apr; 36(17):4698-707. PubMed ID: 27122029
[TBL] [Abstract][Full Text] [Related]
27. Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions.
Islam MS; Tatsumi K; Okuda H; Shiosaka S; Wanaka A
Neurochem Int; 2009; 54(3-4):192-8. PubMed ID: 19070638
[TBL] [Abstract][Full Text] [Related]
28. Astrocyte-targeted production of interleukin-6 reduces astroglial and microglial activation in the cuprizone demyelination model: Implications for myelin clearance and oligodendrocyte maturation.
Petković F; Campbell IL; Gonzalez B; Castellano B
Glia; 2016 Dec; 64(12):2104-2119. PubMed ID: 27535761
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a murine mixed neuron-glia model and cellular responses to regulatory T cell-derived factors.
Dittmer M; Young A; O'Hagan T; Eleftheriadis G; Bankhead P; Dombrowski Y; Medina RJ; Fitzgerald DC
Mol Brain; 2018 May; 11(1):25. PubMed ID: 29720228
[TBL] [Abstract][Full Text] [Related]
30. The cuprizone model: regional heterogeneity of pathology.
Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
[TBL] [Abstract][Full Text] [Related]
31. Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination.
Zhang Y; Zhang H; Wang L; Jiang W; Xu H; Xiao L; Bi X; Wang J; Zhu S; Zhang R; He J; Tan Q; Zhang D; Kong J; Li XM
Schizophr Res; 2012 Jun; 138(1):8-17. PubMed ID: 22555017
[TBL] [Abstract][Full Text] [Related]
32. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
Acs P; Komoly S
Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
[TBL] [Abstract][Full Text] [Related]
33. Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination.
Oluich LJ; Stratton JA; Xing YL; Ng SW; Cate HS; Sah P; Windels F; Kilpatrick TJ; Merson TD
J Neurosci; 2012 Jun; 32(24):8317-30. PubMed ID: 22699912
[TBL] [Abstract][Full Text] [Related]
34. Targeted Oligodendrocyte Apoptosis in Optic Nerve Leads to Persistent Demyelination.
Pajoohesh-Ganji A; Miller RH
Neurochem Res; 2020 Mar; 45(3):580-590. PubMed ID: 30848441
[TBL] [Abstract][Full Text] [Related]
35. Peroxynitrite-induced oligodendrocyte toxicity is not dependent on poly(ADP-ribose) polymerase activation.
Scott GS; Virág L; Szabó C; Hooper DC
Glia; 2003 Jan; 41(2):105-16. PubMed ID: 12509801
[TBL] [Abstract][Full Text] [Related]
36. Olesoxime accelerates myelination and promotes repair in models of demyelination.
Magalon K; Zimmer C; Cayre M; Khaldi J; Bourbon C; Robles I; Tardif G; Viola A; Pruss RM; Bordet T; Durbec P
Ann Neurol; 2012 Feb; 71(2):213-26. PubMed ID: 22367994
[TBL] [Abstract][Full Text] [Related]
37. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions.
Mason JL; Toews A; Hostettler JD; Morell P; Suzuki K; Goldman JE; Matsushima GK
Am J Pathol; 2004 May; 164(5):1673-82. PubMed ID: 15111314
[TBL] [Abstract][Full Text] [Related]
38. Auraptene induces oligodendrocyte lineage precursor cells in a cuprizone-induced animal model of demyelination.
Nakajima M; Shimizu R; Furuta K; Sugino M; Watanabe T; Aoki R; Okuyama S; Furukawa Y
Brain Res; 2016 May; 1639():28-37. PubMed ID: 26944297
[TBL] [Abstract][Full Text] [Related]
39. SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis.
Moll NM; Hong E; Fauveau M; Naruse M; Kerninon C; Tepavcevic V; Klopstein A; Seilhean D; Chew LJ; Gallo V; Nait Oumesmar B
Glia; 2013 Oct; 61(10):1659-72. PubMed ID: 23918253
[TBL] [Abstract][Full Text] [Related]
40. Demyelination initiated by oligodendrocyte apoptosis through enhancing endoplasmic reticulum-mitochondria interactions and Id2 expression after compressed spinal cord injury in rats.
Huang SQ; Tang CL; Sun SQ; Yang C; Xu J; Wang KJ; Lu WT; Huang J; Zhuo F; Qiu GP; Wu XY; Qi W
CNS Neurosci Ther; 2014 Jan; 20(1):20-31. PubMed ID: 23937638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
